Biochips are little laboratories that can execute many biochemical operations at the same time. Biochips are divided into four categories based on their functionality: DNA chips, protein chips, lab-on-a-chips, and tissue and cell arrays. A microscope slide made of materials such as glass, silicon chips, and nylon membrane, which is printed with thousands of minute dots, is used to make DNA chips, biochips, or DNA microarrays. These dots contain an ordered sequence of a recognized DNA sequence or gene. cDNA microarrays, Oligo DNA microarrays, BAC microarrays, and SNP microarrays are examples of DNA microarrays that utilize the nucleic acid hybridization principle. Furthermore, protein microarrays or protein chips have a glass or silicon platform with protein spots organized at certain locations that interact with the probe molecule in a high-throughput manner.
The biochips industry is predicted to develop due to advancements in technology in the biochips platform.
Microarray and microfluidics technologies have transformed scientific research by reducing the time and expenses associated with traditional laboratory-based research methods. Microfluidics has several advantages over traditional laboratory processes, including lower test costs due to the need for less sample in nano-liter or pico-liter volumes, lower personnel costs, and increased sensitivity, accuracy, and throughput. In their respective sectors, devices based on DNA microarrays, protein chips, lab-on-a-chip, and organ-on-a-chip technologies have significantly reduced existing time and cost issues.
The biochips market is growing thanks to ongoing research and development in the field of biochips technology.
The biochips market is growing thanks to ongoing research and development in the field of biochips technology.
Biochips Market technology and applications are a lucrative area, with revenues estimated to reach US$ 26 billion by 2025, growing at a CAGR of 16.2% over the projection period. This is due in part to substantial research and development in the field, which will eventually boost the rate at which these technologies are used. For example, Harvard University scientists have shown that paper and threads may be used to make inexpensive microfluidic devices. Electrodes and electrical textile valves could be included in these gadgets to make them even more helpful. A method of pre-concentration (P-CLIP) was described in a 2017 publication published in the Royal Society of Chemistry, and it may be useful in addressing the problem.
Randox Laboratories, Fluidigm Corporation, Abbott Laboratories, Agilent Technologies, Inc., ThermoFisher Scientific, Inc., Bio-Rad Laboratories, Inc., Illumina, Inc., and PerkinElmer, Inc. are some of the prominent competitors in the biochips industry.
0 Comments